Akebia Therapeutics Inc (AKBA)
SG&A Expenses
$28.17M
Quarterly · Period ending: · USD
AKBA SG&A Expenses
Latest reported$28.17Mperiod ending
Latest reported$28.17Mperiod ending
AKBA Quarterly SG&A Expenses ($1.30M → $28.17M)
Quarterly SG&A Expenses
High-resolution chart · PNG
AKBA sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 28,171,000 | |
| 30,436,000 | |
| 26,089,000 | |
| 29,990,000 | |
| 26,555,000 | |
| 25,742,000 | |
| 27,675,000 | |
| 26,516,000 | |
| 0 | |
| 0 | |
| 25,436,000 | |
| 22,710,000 | |
| 27,036,000 | |
| 25,053,000 | |
| 30,647,000 | |
| 31,887,000 | |
| 32,240,000 | |
| 44,327,000 | |
| 44,804,000 | |
| 46,357,000 | |
| 42,545,000 | |
| 41,328,000 | |
| 40,311,000 | |
| 40,881,000 | |
| 36,526,000 | |
| 38,659,000 | |
| 44,918,000 | |
| 34,178,000 | |
| 36,963,000 | |
| 34,291,000 | |
| 55,121,000 | |
| 10,378,000 | |
| 12,538,000 | |
| 9,024,000 | |
| 7,567,000 | |
| 6,748,000 | |
| 6,905,000 | |
| 5,788,000 | |
| 6,144,000 | |
| 4,944,000 | |
| 5,311,000 | |
| 5,811,000 | |
| 7,511,000 | |
| 3,888,000 | |
| 3,707,000 | |
| 3,391,000 | |
| 3,539,000 | |
| 2,936,000 | |
| 2,315,101 | |
| 3,751,319 | |
| 3,010,621 | |
| 794,000 | |
| 667,783 | |
| 678,923 | |
| 1,297,402 |